The expression of VEGF in HCC tissues or serum implies the vascular invasion and metastasis of HCC, which leads to an increase in the recurrence of HCC after treatment and a decrease in the median survival time of patients (63–66). Here, VEGFA is linked to hepatocellular carcinoma.